Filing Details

Accession Number:
0000904454-24-000391
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-06-20 20:31:31
Reporting Period:
2024-06-17
Accepted Time:
2024-06-20 20:31:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1426800 Assembly Biosciences Inc. ASMB Biological Products, (No Disgnostic Substances) (2836) DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
882095 Gilead Sciences, Inc. 333 Lakeside Drive
Foster City CA 94404
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-06-17 179,500 $0.00 1,268,972 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant to purchase Common Stock Acquisiton 2024-06-17 179,500 $0.00 179,500 $17.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
179,500 2029-06-18 No 4 P Direct
Footnotes
  1. Pursuant to a securities purchase agreement between the Issuer and the Reporting Person, the Issuer issued and sold to the Reporting Person in a private placement 179,500 shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), and a warrant to purchase 179,500 shares of Common Stock (the "Warrant") at a combined price of $15.46 per share of Common Stock and accompanying warrant.
  2. The Warrant is exercisable at any time after the date of issuance and expires on June 18, 2029. A holder of the Warrant may not exercise the Warrant if the holder, together with its affiliates, would beneficially own more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to such exercise.